IMPDH2 and colorectal carcinoma: Overall, these results suggested that IMPDH2 promoted oxaliplatin resistance in CRC cells through the prevention of Caspase 7, Caspase 8, Caspase 9, and PARP1 accumulation, thereby suppressing cell apoptosis.